Medpace Holdings, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Medpace Holdings, Inc. (MEDP) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $4.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-23
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $4.35M, a 26.94% decline year-over-year.
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $4.92M, a 70.89% decline year-over-year.
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $6.32M, a 46.08% decline year-over-year.
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.95M, a 65.86% increase year-over-year.
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $34.79M, a 36.34% increase from fiscal 2024.
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $25.51M, a 24.36% increase from fiscal 2023.
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $20.52M, a 4.18% decline from fiscal 2022.
- Medpace Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $21.41M, a 47.99% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.35M 10-Q · filed 2026-07-23 | $9.27M derived: sum of 2 quarters · filed 2026-07-23 | ||
| 2026-03-31 | $4.92M 10-Q · filed 2026-07-23 | |||
| 2025-12-31 | $34.79M 10-K · filed 2026-02-10 | |||
| 2025-09-30 | $6.32M 10-Q · filed 2025-10-23 | $12.27M derived: sum of 2 quarters · filed 2026-07-23 | $29.17M derived: sum of 3 quarters · filed 2026-07-23 | |
| 2025-06-30 | $5.95M 10-Q · filed 2026-07-23 | $22.84M derived: sum of 2 quarters · filed 2026-07-23 | ||
| 2025-03-31 | $16.89M 10-Q · filed 2026-07-23 | |||
| 2024-12-31 | $25.51M 10-K · filed 2026-02-10 | |||
| 2024-09-30 | $11.73M 10-Q · filed 2025-10-23 | $15.31M derived: sum of 2 quarters · filed 2025-10-23 | $19.63M derived: sum of 3 quarters · filed 2025-10-23 | |
| 2024-06-30 | $3.59M 10-Q · filed 2025-10-23 | $7.90M derived: sum of 2 quarters · filed 2025-10-23 | ||
| 2024-03-31 | $4.31M 10-Q · filed 2025-10-23 | |||
| 2023-12-31 | $20.52M 10-K · filed 2026-02-10 | |||
| 2023-09-30 | $5.01M 10-Q · filed 2024-10-22 | $9.91M derived: sum of 2 quarters · filed 2024-10-22 | $15.35M derived: sum of 3 quarters · filed 2024-10-22 | |
| 2023-06-30 | $4.91M 10-Q · filed 2024-10-22 | $10.34M derived: sum of 2 quarters · filed 2024-10-22 | ||
| 2023-03-31 | $5.44M 10-Q · filed 2024-10-22 | |||
| 2022-12-31 | $21.41M 10-K · filed 2025-02-11 | |||
| 2022-09-30 | $5.79M 10-Q · filed 2023-10-24 | $11.45M derived: sum of 2 quarters · filed 2023-10-24 | $15.82M derived: sum of 3 quarters · filed 2023-10-24 | |
| 2022-06-30 | $5.65M 10-Q · filed 2023-10-24 | $10.03M derived: sum of 2 quarters · filed 2023-10-24 | ||
| 2022-03-31 | $4.37M 10-Q · filed 2023-10-24 | |||
| 2021-12-31 | $14.47M 10-K · filed 2024-02-13 | |||
| 2021-09-30 | $4.05M 10-Q · filed 2022-10-25 | $7.62M derived: sum of 2 quarters · filed 2022-10-25 | $10.49M derived: sum of 3 quarters · filed 2022-10-25 | |
| 2021-06-30 | $3.57M 10-Q · filed 2022-10-25 | $6.44M derived: sum of 2 quarters · filed 2022-10-25 | ||
| 2021-03-31 | $2.87M 10-Q · filed 2022-10-25 | |||
| 2020-12-31 | $13.78M 10-K · filed 2023-02-14 | |||
| 2020-09-30 | $2.76M 10-Q · filed 2021-10-26 | $5.38M derived: sum of 2 quarters · filed 2021-10-26 | $10.82M derived: sum of 3 quarters · filed 2021-10-26 | |
| 2020-06-30 | $2.62M 10-Q · filed 2021-10-26 | $8.06M derived: sum of 2 quarters · filed 2021-10-26 | ||
| 2020-03-31 | $5.45M 10-Q · filed 2021-10-26 | |||
| 2019-12-31 | $20.74M 10-K · filed 2022-02-15 | |||
| 2019-09-30 | $9.47M 10-Q · filed 2020-10-27 | $14.85M derived: sum of 2 quarters · filed 2020-10-27 | $18.03M derived: sum of 3 quarters · filed 2020-10-27 | |
| 2019-06-30 | $5.38M 10-Q · filed 2020-10-27 | $8.57M derived: sum of 2 quarters · filed 2020-10-27 | ||
| 2019-03-31 | $3.18M 10-Q · filed 2020-10-27 | |||
| 2018-12-31 | $6.50M 10-K · filed 2021-02-16 | |||
| 2018-09-30 | $1.43M 10-Q · filed 2019-10-29 | $2.92M derived: sum of 2 quarters · filed 2019-10-29 | $4.39M derived: sum of 3 quarters · filed 2019-10-29 | |
| 2018-06-30 | $1.49M 10-Q · filed 2019-10-29 | $2.95M derived: sum of 2 quarters · filed 2019-10-29 | ||
| 2018-03-31 | $1.47M 10-Q · filed 2019-10-29 | |||
| 2017-12-31 | $4.46M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $2.78M 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $21.13M 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $3.06M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |